DT Investment Partners LLC Sells 7,885 Shares of Medtronic PLC $MDT

DT Investment Partners LLC reduced its holdings in Medtronic PLC (NYSE:MDT) by 82.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,644 shares of the medical technology company’s stock after selling 7,885 shares during the quarter. DT Investment Partners LLC’s holdings in Medtronic were worth $157,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MDT. 1248 Management LLC bought a new stake in shares of Medtronic during the 1st quarter valued at about $26,000. Delos Wealth Advisors LLC purchased a new stake in Medtronic in the second quarter worth about $27,000. Tripletail Wealth Management LLC purchased a new position in shares of Medtronic during the third quarter valued at approximately $34,000. GFG Capital LLC purchased a new stake in shares of Medtronic in the 2nd quarter worth approximately $36,000. Finally, True Wealth Design LLC increased its holdings in shares of Medtronic by 49.8% during the second quarter. True Wealth Design LLC now owns 421 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 140 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

MDT has been the topic of several recent analyst reports. Barclays increased their target price on Medtronic from $109.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, November 20th. Wells Fargo & Company upped their price target on Medtronic from $100.00 to $114.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 19th. UBS Group lifted their price objective on Medtronic from $95.00 to $102.00 and gave the company a “neutral” rating in a research report on Wednesday, November 19th. Royal Bank Of Canada boosted their price objective on Medtronic from $111.00 to $118.00 and gave the company an “outperform” rating in a research report on Wednesday, November 19th. Finally, Leerink Partners set a $120.00 price objective on shares of Medtronic and gave the company an “outperform” rating in a report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $109.94.

Medtronic Trading Down 0.0%

NYSE MDT opened at $96.03 on Monday. The stock has a market cap of $123.11 billion, a PE ratio of 25.88, a PEG ratio of 2.53 and a beta of 0.71. Medtronic PLC has a 12 month low of $79.55 and a 12 month high of $106.33. The company’s 50-day moving average price is $97.65 and its 200-day moving average price is $94.13. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57.

Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business had revenue of $8.96 billion for the quarter, compared to the consensus estimate of $8.86 billion. During the same quarter last year, the firm posted $1.26 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Equities research analysts forecast that Medtronic PLC will post 5.46 earnings per share for the current year.

Medtronic Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s dividend payout ratio is currently 76.55%.

Medtronic Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).